logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yixin Zhou

sun yat-sen university
H指数:21
被引数:1,666

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integration of Untargeted Metabolomics, Network Pharmacology, Single-Cell RNA Sequencing, and Molecular Dynamics Simulation Reveals GOT1, CYP1A2, and CA2 as Potential Targets of Huang Qin Decoction Preventing Colorectal Cancer Liver Metastasis

整合非靶向代谢组学、网络药理学、单细胞RNA测序和分子动力学模拟揭示黄芪汤预防结直肠癌肝转移的潜在靶点GOT1、CYP1A2和CA2

pharmaceuticals
IF0
2025-07-280
OA
Tiegang Li; Zheng Yan; Mingxuan Zhou; Wenyi Zhao; Fang Zhang; Silin Lv; Yufang Hou; Zifan Zeng; Liu Yang; Yixin Zhou; Zengni Zhu; Xinyi Ren; Min Yang
Circulating tumor DNA minimal residual disease predicts the risk of progression after long-term response to first-line immunotherapy in advanced NSCLC

循环肿瘤DNA微小残留病灶预测了晚期非小细胞肺癌对一线免疫治疗长期反应后的进展风险

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
Wu, F.; Peng, Y.; Zeng, Y.; Qiu, Z.; Ma, F.; Zhu, L.; Zhou, C.; Pu, X.; Zhang, L.; Zhou, Y.; Weng, J.; Zengmei, S.; Yu, J.; Zhou, Z.; Meng, R.; Bu, Q.; Liu, P.; Li, J.; Chen, S.; Cui, L.
Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor

通过测量接受PD-1/PD-L1抑制剂治疗的晚期非小细胞肺癌患者中每个器官的单个最大病变来评估肿瘤反应

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2023-10-241
OAAI
He, Li-Na; Chen, Tao; Fu, Sha; Jiang, Yongluo; Zhang, Xuanye; Chen, Chen; Du, Wei; Luo, Linfeng; Li, Anlin; Wang, Yixing; Yu, Hui; Zhou, Yixin; Wang, Yuhong; Yang, Yunpeng; Huang, Yan; Zhao, Hongyun; Fang, Wenfeng; Zhang, Li; Hong, Shaodong

研究方向

暂未获取到该数据
洪
洪少东
H 指数:39论文数:241被引数:7,041
X
Xuanye Zhang
H 指数:15论文数:95被引数:1,005
S
Sha Fu
H 指数:27论文数:135被引数:2,292
L
Lina He
H 指数:21论文数:76被引数:2,891
L
Linfeng Luo
H 指数:8论文数:18被引数:257
W
Wenfeng Fang
H 指数:47论文数:423被引数:9,805
Y
Yunpeng Yang
H 指数:47论文数:382被引数:9,344
B
Bei Zhang
H 指数:31论文数:270被引数:3,535
W
Wei Du
H 指数:10论文数:52被引数:388
L
Li Zhang
H 指数:44论文数:225被引数:6,849